![Comment Letter to the OCC: Licensing Manual Draft Supplement on Evaluating Charter Applications from FinTech Companies](/sites/default/files/styles/search_thumbnail/public/reports-cover/MI-VIEWPOINTS-thumbnail-CRA7_2.jpg?itok=rWQLcyH7)
Comment Letter to the OCC: Licensing Manual Draft Supplement on Evaluating Charter Applications from FinTech Companies
![FinReg21: Modernizing Financial Regulation for the 21st Century](/sites/default/files/styles/search_thumbnail/public/reports-cover/MI-VIEWPOINTS-thumbnail-CRA6_2.jpg?itok=aBYzGcNu)
FinReg21: Modernizing Financial Regulation for the 21st Century
![Promoting Participation in SME Boards Through Tax Incentives: A Global Overview](/sites/default/files/styles/search_thumbnail/public/reports-cover/Tax-Incentives-and-SMEs-Thumbnail_2.jpg?itok=AM2TDHZt)
Promoting Participation in SME Boards Through Tax Incentives: A Global Overview
![Virtuous circle for east Africa: Regional capital market integration is the only option](/sites/default/files/styles/search_thumbnail/public/Virtuous%20circle%20for%20east%20Africa_cover_0_0.jpg?itok=zjFskCI7)
Virtuous circle for east Africa: Regional capital market integration is the only option
![Capital Markets in Rwanda: Assessment and Aspirations](/sites/default/files/styles/search_thumbnail/public/reports-cover/MI-VIEWPOINTS-thumbnail-Backgrounder-Rwanda_2.jpg?itok=Flli24FR)
Capital Markets in Rwanda: Assessment and Aspirations
![California's Infrastructure Convergence: Aligning Development and Human Capital Investments](/sites/default/files/styles/search_thumbnail/public/reports-cover/MI-VIEWPOINTS-thumbnail-CA-Infrastructure_2.jpg?itok=K2CggR3A)
California's Infrastructure Convergence: Aligning Development and Human Capital Investments
![Disruptive Technology and Securities Regulation](/sites/default/files/styles/search_thumbnail/public/reports-cover/Thumbnail-Disruptive-Technology_2.jpg?itok=vn6orAYX)
Disruptive Technology and Securities Regulation
![Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities](/sites/default/files/styles/search_thumbnail/public/Hedging%20Pipeline%20Risk%20in%20Pharma_cover_0.jpg?itok=KPLObSWo)
Hedging Pipeline Risk in Pharma: FDA Swaps and Annuities
![Testimony: U.S. House of Representatives Committee on Financial Services Subcommittee Housing and Insurance: “Sustainable Housing Finance, Part III”](/sites/default/files/styles/search_thumbnail/public/Testimony-U.S.%20House%20of%20Representatives%20Committee%20on%20Financial%20Services_cover_0.png?itok=9MQbAAKO)
Testimony: U.S. House of Representatives Committee on Financial Services Subcommittee Housing and Insurance: “Sustainable Housing Finance, Part III”
![Comment Letter: Policy on No-Action Letters and the CFPB Product Sandbox](/sites/default/files/styles/search_thumbnail/public/Comment%20Letter-Policy%20on%20No-Action%20Letters%20and%20the%20CFPB%20Product%20Sandbox_cover_0.jpg?itok=tAOaX-KH)
Comment Letter: Policy on No-Action Letters and the CFPB Product Sandbox
![Comment Letter to the OCC: Special Purpose National Bank Charters for FinTech Companies](/sites/default/files/styles/search_thumbnail/public/Comment%20Letter-%20to%20the%20OCC%20Special%20Purpose%20National%20Bank%20Charters%20for%20FinTech%20Companies_cover_0.png?itok=lfsPgXNc)
Comment Letter to the OCC: Special Purpose National Bank Charters for FinTech Companies
![Misdiagnosis: Incomplete Cures of Financial Regulatory Failures](/sites/default/files/styles/search_thumbnail/public/reports-cover/miphW_8.png?itok=K_HzJTP_)